Bill Crounse, MD, Senior Director for Worldwide Health, Microsoft Corporation, discusses his views on the lack of healthcare IT in the US. For the Bill Crounse, MD blog…
James P. Moises, MD, Assistant Clinical Professor of Surgery, Department of Emergency Medicine, Clerkship Director of Emergency Medicine, Tulane University Hospital and Clinic, discusses his thoughts on the…
Howard (Jack) West, MD, Medical Director, Thoracic Oncology Program Swedish Cancer Institute, President & CEO, Global Resource for Advancing Cancer Education (GRACE), Seattle, WA, discusses his thoughts on…
Jeffrey M. Lipton, MD, Ph.D, Chief Pediatric Hematology/Oncology and Stem Cell Transplantation, Schneider Children’s Hospital, and Professor of Pediatrics at Albert Einstein College of Medicine, discusses cord blood.…
A tablet that combines sumatriptan and naproxen (Treximet) has been approved by the FDA for treatment of migraine with and without aura. References and Resources FDA Sponsored by…
An investigational compound for chronic plaque psoriasis has shown to be safe and effective. In an industry-sponsored phase III trial, the calcineurin inhibitor ISA247 significantly reduced the extent…
Oded Preis, MD, FAAP, Associate Clinical Professor of Pediatrics, SUNY Downstate Brooklyn, discusses who he believes should be the payee for vaccines. Submitted by: Dr. Melvin Koplow
Michael Marcus, MD, Stony Brook University Health Sciences Center, Stony Brook, NY, discusses the difference between the common cold and allergies in pediatric patients. Submitted by: Dr. Melvin…
Greg Foltz, MD, Director, Center for Advanced Brain Tumor Treatment, Swedish Neuroscience Institute, Seattle, Washington, discusses the Center for Advanced Brain Tumor Treatment. For more information visit: Center…
Greg Foltz, MD, Director, Center for Advanced Brain Tumor Treatment, Swedish Neuroscience Institute, Seattle, WA, discusses current treatments for brain cancer. References and Resources Schönekaes K, Mücke R,…
